The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation

被引:156
作者
Gill, JS
Tonelli, M
Johnson, N
Kiberd, B
Landsberg, D
Pereira, BJG
机构
[1] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC V5Z 1M9, Canada
[2] Tufts New England Med Ctr, Boston, MA USA
[3] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada
[4] Inst Hlth Econ, Edmonton, AB, Canada
[5] Dalhousie Univ, Halifax, NS, Canada
关键词
kidney transplantation; patient survival; waiting time; comorbid conditions;
D O I
10.1111/j.1523-1755.2005.00696.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Longer waiting times may limit the survival benefit of kidney transplantation in older patients or those with a high burden of comorbid disease. Methods. We performed a longitudinal study of mortality among 63,783 transplant candidates who started dialysis between April 1995 and December 2000. We determined the relative risk (RR) of death and increase in life expectancy among subjects who received a first deceased donor transplant after different waiting times compared to subjects who had equivalent waiting times but remained on dialysis. Results. Transplant recipients had a lower long-term RR of death and the risk reduction was greatest in recipients with longer waiting times (RR of death 12 months after transplantation for recipients with waiting times of 0, 1, 2, 3 years was 0.49, 0.43, 0.38, 0.34, P= 0.0006).The average increase in life expectancy in transplant recipients was 9.8 years and was lower in older recipients and recipients with comorbid conditions. Increased waiting times from 1 to 3 years only moderately decreased the overall survival benefit of transplantation from 7.1 to 5.6 years, and all subjects derived a survival benefit from transplantation with waiting times up to 3 years. Conclusion. These findings do not support limiting access to transplantation for otherwise suitable candidates on the basis of longer anticipated waiting times.
引用
收藏
页码:2345 / 2351
页数:7
相关论文
共 15 条
[1]  
ALLISON PD, 2000, SURVIVAL ANAL USING
[2]   Patient survival after renal transplantation: I. The impact of dialysis pre-transplant [J].
Cosio, FG ;
Alamir, A ;
Yim, S ;
Pesavento, TE ;
Falkenhain, ME ;
Henry, ML ;
Elkhammas, EA ;
Davies, EA ;
Bumgardner, GL ;
Ferguson, RM .
KIDNEY INTERNATIONAL, 1998, 53 (03) :767-772
[3]  
Danovitch GM, 2002, J AM SOC NEPHROL, V13, P528, DOI 10.1681/ASN.V132528
[4]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[5]  
Kasiske BL, 1996, J AM SOC NEPHROL, V7, P158
[6]  
Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1
[7]   A study of the quality of life and cost-utility of renal transplantation [J].
Laupacis, A ;
Keown, P ;
Pus, N ;
Krueger, H ;
Ferguson, B ;
Wong, C ;
Muirhead, N .
KIDNEY INTERNATIONAL, 1996, 50 (01) :235-242
[8]   Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? [J].
Levey, AS ;
Beto, JA ;
Coronado, BE ;
Eknoyan, G ;
Foley, RN ;
Kasiske, BL ;
Klag, MJ ;
Mailloux, LU ;
Manske, CL ;
Meyer, KB ;
Parfrey, PS ;
Pfeffer, MA ;
Wenger, NK ;
Wilson, PWF ;
Wright, JT .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :853-906
[9]   Effect of waiting time on renal transplant outcome [J].
Meier-Kriesche, HU ;
Port, FK ;
Ojo, AO ;
Rudich, SM ;
Hanson, JA ;
Cibrik, DM ;
Leichtman, AB ;
Kaplan, B .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1311-1317
[10]  
Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x